Huijuan Yang

9PUBLICATIONS
13CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 22, 2024
Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.

Yi Wang, Misi He, Tiancong He

|Apr 12, 2022
Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features.

Shuang Ye, Wei Chen, Yuwei Zheng

|Jan 19, 2022
Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma.

Shuang Ye, Qin Li, Yutuan Wu

|Aug 31, 2021
Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery.

Wei Chen, Shuang Ye, Yutuan Wu

|Nov 12, 2019
Highly immunosuppressive HLADRhi regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma.

Huijuan Yang, Shuang Ye, Shyamal Goswami

|Dec 15, 2018
The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer.

Wei Jiang, Tiancong He, Shuai Liu

Pageof 2

Frequent Collaborators

2 joint publications

Tiancong He

2 joint publications

Xuxia Shen

2 joint publications

Xiaohua Wu

2 joint publications

Shengling Huang